Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Statins may lower risk of colorectal cancer

Publish date:: October 28, 2020

Key clinical point: Statin use may lower the risk of colorectal cancer (CRC) in patients with or without inflammatory bowel disease (IBD).

Major finding: Patients with IBD who used statins had a 60% lower risk of CRC (pooled odds ratio, 0.40; 95% confidence interval, 0.19-0.86; P = .019).

Study details: A systematic review and meta-analysis of 52 studies involving 11,459,306 patients.

Disclosures: The investigators and Dr. Kaplan reported no relevant conflicts of interest.

Citation:

FROM ACG 2020

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Colorectal Cancer

Geography and behaviors linked to early-onset colorectal cancer survival in U.S. women,

Statins may lower risk of colorectal cancer,